Of these, 20 were assigned to receive 5 mcg of subcutaneous exenatide twice daily for 1 month, followed by 10 mcg twice daily for 11 months, while 24 were placed in the control group
They also work by slowing down movement of food through the stomach and curbing appetite, thereby causing weight loss
Men with Class I obesity lost an average of 17.4 kg (38 pounds), while those with Class III obesity lost 25.3 kg (56 pounds)
On the drug pricing front, the Trump administration brokered most-favored-nation (MFN) pricing deals with Novo Nordisk and Eli Lilly in November 2025, reducing GLP-1 prices for Medicare/Medicaid to approximately $245/month and launching a direct-to-consumer platform (TrumpRx) offering prices around $350/month ( [17] )
Understanding how dermatologists diagnose pigmentation issues helps set realistic expectations
A Small-Molecule Oral Agonist of the Human Glucagon-like Peptide-1 Receptor